132 related articles for article (PubMed ID: 2327990)
1. Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein.
Chen LM; Chao L; Mayfield RK; Chao J
Biochem J; 1990 Apr; 267(1):79-84. PubMed ID: 2327990
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new tissue-kallikrein-binding protein.
Chao J; Tillman DM; Wang MY; Margolius HS; Chao L
Biochem J; 1986 Oct; 239(2):325-31. PubMed ID: 3643793
[TBL] [Abstract][Full Text] [Related]
3. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence.
Zhou GX; Chao L; Chao J
J Biol Chem; 1992 Dec; 267(36):25873-80. PubMed ID: 1334488
[TBL] [Abstract][Full Text] [Related]
4. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein.
Chen VC; Chao L; Chao J
J Biol Chem; 2000 Dec; 275(51):40371-7. PubMed ID: 10991942
[TBL] [Abstract][Full Text] [Related]
5. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes.
Perlmutter DH; Glover GI; Rivetna M; Schasteen CS; Fallon RJ
Proc Natl Acad Sci U S A; 1990 May; 87(10):3753-7. PubMed ID: 2160076
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of rat kallikrein-binding protein in Escherichia coli.
Ma JX; Chao L; Zhou G; Chao J
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):825-32. PubMed ID: 8318011
[TBL] [Abstract][Full Text] [Related]
7. Determination of tissue kallikrein and alpha 1-antitrypsin-tissue kallikrein complexes in synovial fluid of patients with rheumatoid, osteo and psoriatic arthritis.
Rahman MM; Worthy K; Elson CJ; Dieppe PA; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 3)():389-96. PubMed ID: 1462872
[TBL] [Abstract][Full Text] [Related]
8. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.
Wachtfogel YT; Hack CE; Nuijens JH; Kettner C; Reilly TM; Knabb RM; Bischoff R; Tschesche H; Wenzel H; Kucich U
Am J Physiol; 1995 Mar; 268(3 Pt 2):H1352-7. PubMed ID: 7535008
[TBL] [Abstract][Full Text] [Related]
9. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats.
Chao J; Chao L
J Hypertens; 1988 Jul; 6(7):551-7. PubMed ID: 3171170
[TBL] [Abstract][Full Text] [Related]
10. Human kallistatin, a new tissue kallikrein-binding protein: purification and characterization.
Wang MY; Day J; Chao L; Chao J
Adv Exp Med Biol; 1989; 247B():1-8. PubMed ID: 2558505
[TBL] [Abstract][Full Text] [Related]
11. Cross-competition for binding of alpha 1-antitrypsin (alpha 1 AT)-elastase complexes to the serpin-enzyme complex receptor by other serpin-enzyme complexes and by proteolytically modified alpha 1 AT.
Joslin G; Wittwer A; Adams S; Tollefsen DM; August A; Perlmutter DH
J Biol Chem; 1993 Jan; 268(3):1886-93. PubMed ID: 8380581
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.
Ecke S; Geiger M; Resch I; Jerabek I; Sting L; Maier M; Binder BR
J Biol Chem; 1992 Apr; 267(10):7048-52. PubMed ID: 1313031
[TBL] [Abstract][Full Text] [Related]
13. Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha 1-antitrypsin (alpha 1-protease inhibitor).
Geiger R; Stuckstedte U; Clausnitzer B; Fritz H
Hoppe Seylers Z Physiol Chem; 1981 Mar; 362(3):317-25. PubMed ID: 6971794
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human tissue kallikrein by alpha 1-proteinase inhibitor.
Hirano K; Okumura Y; Hayakawa S; Adachi T; Sugiura M
Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):27-32. PubMed ID: 6201429
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
Scott CF; Carrell RW; Glaser CB; Kueppers F; Lewis JH; Colman RW
J Clin Invest; 1986 Feb; 77(2):631-4. PubMed ID: 3484755
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
[TBL] [Abstract][Full Text] [Related]
17. Tissue kallikrein inhibitors in mammals.
Chao J; Chai KX; Chao L
Immunopharmacology; 1996 May; 32(1-3):67-72. PubMed ID: 8796269
[TBL] [Abstract][Full Text] [Related]
18. The SEC receptor recognizes a pentapeptide neodomain of alpha 1-antitrypsin-protease complexes.
Joslin G; Fallon RJ; Bullock J; Adams SP; Perlmutter DH
J Biol Chem; 1991 Jun; 266(17):11282-8. PubMed ID: 1645729
[TBL] [Abstract][Full Text] [Related]
19. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein.
Xiong W; Tang CQ; Zhou GX; Chao L; Chao J
J Lab Clin Med; 1992 May; 119(5):514-21. PubMed ID: 1583408
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of urinary kallikrein by alpha 1-antitrypsin.
Hörl WH; Heidland A
Klin Wochenschr; 1981 Jul; 59(13):761-3. PubMed ID: 6973046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
